Skip to content
Search

Latest Stories

Expand pharmacy role in vaccination delivery to boost uptake - CCA urges NHSE

CCA urges NHSE to commission pharmacies to deliver more vaccinations
gettyimages

Pharmacies can boost confidence in vaccination, especially amongst underserved communities

Commissioning pharmacies to deliver more vaccinations -– including pneumonia, shingles, meningitis, RSV and other routine childhood vaccines – could free up 10 million GP vaccination appointments each year, according to a new report by the Company Chemists’ Association (CCA).

This shift would enable GPs to focus on providing care to patients with more complex needs, improve vaccine access for underserved communities, reverse declining uptake, and free up hospital beds at a critical time for the NHS – the report said.


Highlighting the crucial role pharmacies play in vaccination delivery, the report revealed: “Pharmacies have administered over 42 million Covid vaccinations between December 2020 and August 2024, more than a quarter of the 165 million Covid vaccines delivered so far.”

In spring 2024, more than half of all Covid vaccinations given to Black/Black British, Asian/Asian British, mixed ethnicity, and Chinese or other ethnicity groups were administered in pharmacies.

These groups, previously identified as having higher levels of vaccine hesitancy, benefited significantly from the accessibility of pharmacy services, the report noted.

Additionally, previous research cited in the report found that pharmacy colleagues were considered to be trusted sources of information and held strong relationships with the local community, with patients visiting pharmacies 12 times more frequently than GPs.

With more pharmacies in areas of higher deprivation, their convenient locations and extended opening hours, pharmacies provide accessible care to patients, particularly those in underserved communities.

CCA chief executive Malcolm Harrison emphasised that vaccines are one of the “most effective tools in our armoury” to prevent ill-health.

“Pharmacies have proven time and time again that they can boost uptake and confidence in vaccination, especially amongst underserved communities.

“Pharmacies could deliver 10 million more vaccinations each year – freeing up GP capacity and hospital beds, but also ensuring patients and members of the public could be vaccinated where and when they want,” he said.

Harrison also called on NHS England to “build on community pharmacy’s track record in the flu and Covid-19 vaccination programme, and commission pharmacies to administer a whole range of NHS vaccines.”

The report underscored that in 2023/24, no childhood vaccines met the World Health Organisation (WHO) target coverage rate of 95 per cent. It suggested that community pharmacies could play a critical role in increasing uptake.

One example cited was a pharmacy MMR vaccine programme commissioned earlier this year in response to a concerning rise in cases of measles in Northwest England.

NHS figures showed that nearly one in six children had not received both doses of the MMR vaccine by the age of five.

Both doses are essential for long-term protection against measles, mumps and rubella, which can cause serious illness and complications such as blindness and meningitis.

For individuals over the age of five who have not completed their MMR vaccination schedule, 43 pharmacies across Greater Manchester, Cheshire, Merseyside, Lancashire, and South Cumbria now offer the vaccine.

This programme harnesses the accessibility of pharmacies to increase the uptake of the MMR vaccine in high-risk areas.

Responding to the CCA report, Nick Kaye, chair of the National Pharmacy Association (NPA), stated that they have consistently advocated for an expanded role in vaccination within the NHS to help protect the population against other illnesses such as pneumonia.

“The sector’s impressive track record in public health, the potential to address health inequalities and the unparalleled access offered by pharmacies create a very strong case for service development in this sphere,” he added.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less